Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
WAVE Life Sciences Ltd. (WVE) had Normalized Pre-Tax Income of $-50.47M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$8.70M |
|
$-50.47M |
|
-- |
|
$8.70M |
|
$61.46M |
|
$-52.76M |
|
$2.29M |
|
$-50.47M |
|
|
Normalized Pre-Tax Income |
$-50.47M |
$-50.47M |
|
$-50.47M |
|
$-50.47M |
|
$-50.47M |
|
$-52.76M |
|
$-50.56M |
|
163.99M |
|
163.99M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$223.56M |
|
$9.04M |
|
$28.80M |
|
$252.35M |
|
$87.41M |
|
-- |
|
$25.68M |
|
$113.09M |
|
$139.27M |
|
$139.27M |
|
$139.27M |
|
155.67M |
|
| Cash Flow Statement Financials | |
$-109.05M |
|
$-0.47M |
|
$15.85M |
|
$305.84M |
|
$212.26M |
|
$-93.57M |
|
$11.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-606.49% |
|
-606.49% |
|
-- |
|
-580.17% |
|
-580.17% |
|
$-109.52M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
5.38 |
|
16.73 |
|
-36.24% |
|
-36.24% |
|
-20.00% |
|
-36.24% |
|
$0.89 |
|
$-0.67 |
|
$-0.67 |
|